0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-11140
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Meningococcal Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Meningococcal Vaccine Market Research Report 2024

Code: QYRE-Auto-11140
Report
January 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meningococcal Vaccine Market Size

The global Meningococcal Vaccine market was valued at US$ 262 million in 2023 and is anticipated to reach US$ 355.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Meningococcal Vaccine Market

Meningococcal Vaccine Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Vaccine.

Report Scope

The Meningococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (10K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Meningococcal Vaccine Market Report

Report Metric Details
Report Name Meningococcal Vaccine Market
Accounted market size in 2023 US$ 262 million
Forecasted market size in 2030 US$ 355.4 million
CAGR 4.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Meningtits A
  • Polysaccharide Meningtitis AC
  • Meningitis ACYW
Segment by Application
  • 6 Months-15Year
  • over 3 Year
  • over 2 Year
  • over 3 Months
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meningococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meningococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Meningococcal Vaccine Market growing?

Ans: The Meningococcal Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2024-2030.

What is the Meningococcal Vaccine Market size in 2030?

Ans: The Meningococcal Vaccine Market size in 2030 will be US$ 355.4 million.

What is the market share of major companies in Meningococcal Vaccine Market?

Ans: Global top five players hold a share about 80%.

What is the Meningococcal Vaccine Market share by type?

Ans: In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%.

Who are the main players in the Meningococcal Vaccine Market report?

Ans: The main players in the Meningococcal Vaccine Market are Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei

What are the Application segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Applications covered in the Meningococcal Vaccine Market report are 6 Months-15Year, over 3 Year, over 2 Year, over 3 Months

What are the Type segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Types covered in the Meningococcal Vaccine Market report are Meningtits A, Polysaccharide Meningtitis AC, Meningitis ACYW

1 Meningococcal Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Vaccine
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Global Meningococcal Vaccine Market Value by Application: (2024-2030)
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Global Meningococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccine Revenue 2019-2030
1.4.2 Global Meningococcal Vaccine Sales 2019-2030
1.4.3 Global Meningococcal Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meningococcal Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meningococcal Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Meningococcal Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Vaccine, Product Type & Application
2.7 Meningococcal Vaccine Market Competitive Situation and Trends
2.7.1 Meningococcal Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meningococcal Vaccine Players Market Share by Revenue
2.7.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningococcal Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meningococcal Vaccine Global Meningococcal Vaccine Sales by Region: 2019-2030
3.2.1 Global Meningococcal Vaccine Sales by Region: 2019-2024
3.2.2 Global Meningococcal Vaccine Sales by Region: 2025-2030
3.3 Global Meningococcal Vaccine Global Meningococcal Vaccine Revenue by Region: 2019-2030
3.3.1 Global Meningococcal Vaccine Revenue by Region: 2019-2024
3.3.2 Global Meningococcal Vaccine Revenue by Region: 2025-2030
3.4 North America Meningococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meningococcal Vaccine Sales by Country (2019-2030)
3.4.3 North America Meningococcal Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meningococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meningococcal Vaccine Sales by Country (2019-2030)
3.5.3 Europe Meningococcal Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Meningococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meningococcal Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Meningococcal Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Meningococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meningococcal Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Meningococcal Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meningococcal Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meningococcal Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Vaccine Sales by Type (2019-2030)
4.1.1 Global Meningococcal Vaccine Sales by Type (2019-2024)
4.1.2 Global Meningococcal Vaccine Sales by Type (2025-2030)
4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Meningococcal Vaccine Revenue by Type (2019-2030)
4.2.1 Global Meningococcal Vaccine Revenue by Type (2019-2024)
4.2.2 Global Meningococcal Vaccine Revenue by Type (2025-2030)
4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Meningococcal Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meningococcal Vaccine Sales by Application (2019-2030)
5.1.1 Global Meningococcal Vaccine Sales by Application (2019-2024)
5.1.2 Global Meningococcal Vaccine Sales by Application (2025-2030)
5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Meningococcal Vaccine Revenue by Application (2019-2030)
5.2.1 Global Meningococcal Vaccine Revenue by Application (2019-2024)
5.2.2 Global Meningococcal Vaccine Revenue by Application (2025-2030)
5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Meningococcal Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Meningococcal Vaccine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Meningococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Meningococcal Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 CSL
6.4.1 CSL Corporation Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Meningococcal Vaccine Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter Meningococcal Vaccine Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 JN International Medical Corporation
6.6.1 JN International Medical Corporation Corporation Information
6.6.2 JN International Medical Corporation Description and Business Overview
6.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
6.6.5 JN International Medical Corporation Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Meningococcal Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Meningococcal Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 China National Biotec Group
6.9.1 China National Biotec Group Corporation Information
6.9.2 China National Biotec Group Description and Business Overview
6.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Group Meningococcal Vaccine Product Portfolio
6.9.5 China National Biotec Group Recent Developments/Updates
6.10 Hualan Bio
6.10.1 Hualan Bio Corporation Information
6.10.2 Hualan Bio Description and Business Overview
6.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hualan Bio Meningococcal Vaccine Product Portfolio
6.10.5 Hualan Bio Recent Developments/Updates
6.11 Walvax
6.11.1 Walvax Corporation Information
6.11.2 Walvax Meningococcal Vaccine Description and Business Overview
6.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Walvax Meningococcal Vaccine Product Portfolio
6.11.5 Walvax Recent Developments/Updates
6.12 Zhifei
6.12.1 Zhifei Corporation Information
6.12.2 Zhifei Meningococcal Vaccine Description and Business Overview
6.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhifei Meningococcal Vaccine Product Portfolio
6.12.5 Zhifei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Vaccine Industry Chain Analysis
7.2 Meningococcal Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Vaccine Production Mode & Process
7.4 Meningococcal Vaccine Sales and Marketing
7.4.1 Meningococcal Vaccine Sales Channels
7.4.2 Meningococcal Vaccine Distributors
7.5 Meningococcal Vaccine Customers
8 Meningococcal Vaccine Market Dynamics
8.1 Meningococcal Vaccine Industry Trends
8.2 Meningococcal Vaccine Market Drivers
8.3 Meningococcal Vaccine Market Challenges
8.4 Meningococcal Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Meningococcal Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Meningococcal Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Meningococcal Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Meningococcal Vaccine Sales (10K Pcs) of Key Manufacturers (2019-2024)
    Table 5. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Meningococcal Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Meningococcal Vaccine Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Meningococcal Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
    Table 18. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)
    Table 20. Global Meningococcal Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Meningococcal Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Meningococcal Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
    Table 27. North America Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
    Table 28. North America Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
    Table 32. Europe Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
    Table 33. Europe Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Meningococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)
    Table 37. Asia Pacific Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)
    Table 38. Asia Pacific Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
    Table 42. Latin America Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
    Table 43. Latin America Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)
    Table 47. Middle East & Africa Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)
    Table 48. Middle East & Africa Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2019-2024)
    Table 51. Global Meningococcal Vaccine Sales (10K Pcs) by Type (2025-2030)
    Table 52. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Meningococcal Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Meningococcal Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Meningococcal Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2019-2024)
    Table 59. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2025-2030)
    Table 60. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2019-2024)
    Table 61. Global Meningococcal Vaccine Sales (10K Pcs) by Application (2025-2030)
    Table 62. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Meningococcal Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Meningococcal Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Meningococcal Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Meningococcal Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2019-2024)
    Table 69. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2025-2030)
    Table 70. Novartis Corporation Information
    Table 71. Novartis Description and Business Overview
    Table 72. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 73. Novartis Meningococcal Vaccine Product
    Table 74. Novartis Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 78. GSK Meningococcal Vaccine Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Merck Corporation Information
    Table 81. Merck Description and Business Overview
    Table 82. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 83. Merck Meningococcal Vaccine Product
    Table 84. Merck Recent Developments/Updates
    Table 85. CSL Corporation Information
    Table 86. CSL Description and Business Overview
    Table 87. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 88. CSL Meningococcal Vaccine Product
    Table 89. CSL Recent Developments/Updates
    Table 90. Baxter Corporation Information
    Table 91. Baxter Description and Business Overview
    Table 92. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 93. Baxter Meningococcal Vaccine Product
    Table 94. Baxter Recent Developments/Updates
    Table 95. JN International Medical Corporation Corporation Information
    Table 96. JN International Medical Corporation Description and Business Overview
    Table 97. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 98. JN International Medical Corporation Meningococcal Vaccine Product
    Table 99. JN International Medical Corporation Recent Developments/Updates
    Table 100. Serum Institute of India Corporation Information
    Table 101. Serum Institute of India Description and Business Overview
    Table 102. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 103. Serum Institute of India Meningococcal Vaccine Product
    Table 104. Serum Institute of India Recent Developments/Updates
    Table 105. Bio-Med Corporation Information
    Table 106. Bio-Med Description and Business Overview
    Table 107. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 108. Bio-Med Meningococcal Vaccine Product
    Table 109. Bio-Med Recent Developments/Updates
    Table 110. China National Biotec Group Corporation Information
    Table 111. China National Biotec Group Description and Business Overview
    Table 112. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 113. China National Biotec Group Meningococcal Vaccine Product
    Table 114. China National Biotec Group Recent Developments/Updates
    Table 115. Hualan Bio Corporation Information
    Table 116. Hualan Bio Description and Business Overview
    Table 117. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 118. Hualan Bio Meningococcal Vaccine Product
    Table 119. Hualan Bio Recent Developments/Updates
    Table 120. Walvax Corporation Information
    Table 121. Walvax Description and Business Overview
    Table 122. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 123. Walvax Meningococcal Vaccine Product
    Table 124. Walvax Recent Developments/Updates
    Table 125. Zhifei Corporation Information
    Table 126. Zhifei Description and Business Overview
    Table 127. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 128. Zhifei Meningococcal Vaccine Product
    Table 129. Zhifei Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Meningococcal Vaccine Distributors List
    Table 133. Meningococcal Vaccine Customers List
    Table 134. Meningococcal Vaccine Market Trends
    Table 135. Meningococcal Vaccine Market Drivers
    Table 136. Meningococcal Vaccine Market Challenges
    Table 137. Meningococcal Vaccine Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Meningococcal Vaccine
    Figure 2. Global Meningococcal Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Meningococcal Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Meningtits A Product Picture
    Figure 5. Polysaccharide Meningtitis AC Product Picture
    Figure 6. Meningitis ACYW Product Picture
    Figure 7. Global Meningococcal Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Meningococcal Vaccine Market Share by Application in 2023 & 2030
    Figure 9. 6 Months-15Year
    Figure 10. over 3 Year
    Figure 11. over 2 Year
    Figure 12. over 3 Months
    Figure 13. Global Meningococcal Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Meningococcal Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Meningococcal Vaccine Sales (2019-2030) & (10K Pcs)
    Figure 16. Global Meningococcal Vaccine Average Price (USD/Pcs) & (2019-2030)
    Figure 17. Meningococcal Vaccine Report Years Considered
    Figure 18. Meningococcal Vaccine Sales Share by Manufacturers in 2023
    Figure 19. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Meningococcal Vaccine Players: Market Share by Revenue in 2023
    Figure 21. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Meningococcal Vaccine Sales Market Share by Country (2019-2030)
    Figure 24. North America Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Meningococcal Vaccine Sales Market Share by Country (2019-2030)
    Figure 28. Europe Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2019-2030)
    Figure 36. China Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Meningococcal Vaccine Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Meningococcal Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Meningococcal Vaccine by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Meningococcal Vaccine by Type (2019-2030)
    Figure 57. Global Meningococcal Vaccine Price (USD/Pcs) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Meningococcal Vaccine by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Meningococcal Vaccine by Application (2019-2030)
    Figure 60. Global Meningococcal Vaccine Price (USD/Pcs) by Application (2019-2030)
    Figure 61. Meningococcal Vaccine Value Chain
    Figure 62. Meningococcal Vaccine Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS